Lemeng Zhang
Impact in
- Immunology top 5%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Response and Inflammation
- Immune cells in cancer
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research
Papers in
-
- RNA modifications and cancer 6
- Inflammasome and immune disorders 6
-
- Lung Cancer Treatments and Mutations 9
- Ferroptosis and cancer prognosis 5
- Co-authors
- Xiaoli Su (12 shared papers)Hongyi Tan (9 shared papers)Allan Tsung (5 shared papers)Hai Huang (4 shared papers)Haitao Li (14 shared papers)Pinhua Pan (10 shared papers)Gary Nace (3 shared papers)Timothy R. Billiar (4 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Scientific Reports (3 papers)Tobacco Induced Diseases (3 papers)BioMed Research International (3 papers)Friction (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lemeng Zhang
73 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 137
- Immunology 862
- Clinical Biochemistry 186
- Cancer Research 356
- Molecular Biology 1.0k
- Pulmonary and Respiratory Medicine 434
Countries citing papers authored by Lemeng Zhang
This map shows the geographic impact of Lemeng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lemeng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lemeng Zhang more than expected).
Fields of papers citing papers by Lemeng Zhang
This network shows the impact of papers produced by Lemeng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lemeng Zhang. The network helps show where Lemeng Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lemeng Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 288 | |
| 2 | 2012 | 252 | |
| 3 | 2010 | 213 | |
| 4 | 2016 | 204 | |
| 5 | 2019 | 157 | |
| 6 | 2018 | 131 | |
| 7 | 2015 | 87 | |
| 8 | 2016 | 67 | |
| 9 | 2017 | 65 | |
| 10 | 2018 | 65 | |
| 11 | 2015 | 61 | |
| 12 | 2016 | 56 | |
| 13 | 2011 | 39 | |
| 14 | 2017 | 38 | |
| 15 | 2017 | 36 | |
| 16 | 2018 | 31 | |
| 17 | 2022 | 31 | |
| 18 | 2012 | 30 | |
| 19 | 2020 | 28 | |
| 20 | 2020 | 25 |
About Lemeng Zhang
Lemeng Zhang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Immunology, Oncology and Cancer Research, having authored 78 papers that have together received 2.5k indexed citations. Recurring topics across this work include Immune Response and Inflammation (13 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (9 papers), Lung Cancer Treatments and Mutations (9 papers), Autophagy in Disease and Therapy (7 papers), RNA modifications and cancer (6 papers), Inflammasome and immune disorders (6 papers), Ferroptosis and cancer prognosis (5 papers) and Lung Cancer Research Studies (5 papers). The work is most often cited by research in Immunology (862 citations), Clinical Biochemistry (186 citations), Cancer Research (356 citations), Molecular Biology (1.0k citations) and Pulmonary and Respiratory Medicine (434 citations). Lemeng Zhang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiaoli Su, Hongyi Tan, Allan Tsung, Hai Huang, Haitao Li, Pinhua Pan, Gary Nace, Timothy R. Billiar, Dongdong Wu and John Evankovich. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports, Tobacco Induced Diseases, BioMed Research International and Friction.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.